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Abstract
Background: Roux-en-Y gastric bypass (RYGB) is currently the most 
effective treatment of morbid obesity in man. In rodents, RYGB leads to 
a number of morphological changes in the intestine. However, little is 
known about the effect of RYGB surgery on intestinal morphology and 
enteroendocrine L-cells in larger animals and man. Here we performed 
RYGB surgery in obese Göttingen minipigs, to assess whether the 
intervention is associated with changes in intestinal volume, L-cell 
number and plasma levels of glucose, insulin, glucagon-like peptide-1 
(GLP-1) and leptin.
Methods: The study included five RYGB operated and three non-
operated obese Göttingen minipigs (body weight 99 ± 7.7 kg). Plasma 
samples were obtained for assessment of glucose, insulin, GLP-1 and 
leptin pre- and post- RYGB surgery. The pigs were euthanized eight 
to nine months post-surgery and the gut processed for stereological 
assessments of intestinal volume and L-cell number. 
Results: RYGB led to a sustained reduction of body weight of 
~14% in two animals (responders), whereas three animals regained 
body weight to pre-surgical levels (non-responders). Postprandial 
plasma levels of glucose and insulin were unchanged in all animals 
post-surgery, whereas postprandial GLP-1 levels increased in both 
responders and non-responders and leptin levels decreased with 
the most pronounced improvement in responders. Variations in body 
weight loss were reflected in changes in length of alimentary limb, 
intestinal volume and total L-cell number of the alimentary limb.
Conclusion: Body weight loss following RYGB surgery in obese 
Göttingen minipigs is associated with an increase in intestinal volume, 
total L-cell number, and postprandial plasma GLP-1 levels. These 
changes are most pronounced in the alimentary limb suggesting that 
the changes here may be a key determinant to the success of RYGB 
surgery. 
Abbreviations
RYGB: Roux-en-Y Gastric Bypass; GLP-1: Glucagon-Like 
Peptide-1; GLP-2: Glucagon-Like Peptide-2; IVGTT: Intra Venous 
Glucose Tolerance Test; MMT: Mixed Meal Test; PYY: Peptide YY
Introduction
Obesity is considered one of the most serious threats to public 
health with over 2.8 million people dying each year due to obesity 
related pathology [1]. Currently, only a few pharmacological 
treatments are available, which all show poor efficacy and/or many 
adverse effects. In contrast, bariatric surgery including Roux-en-Y 
gastric bypass (RYGB) leads to sustained weight loss, but also 
resolution of type 2 diabetes mellitus and improvement in other co-
morbidities like arterial hypertension and atherosclerosis [2,3]. 
Not all individuals respond equally well to RYGB surgery and 
the exact mechanisms underlying the weight loss and anti-diabetic 
effects are not fully understood. It is generally accepted that release of 
gut hormones such as glucagon-like-peptide 1 (GLP-1) and peptide 
YY (PYY) as well as intestinal growth factors play important roles 
[4,5]. Previous studies have consistently shown increased plasma 
levels of GLP-1 and PYY following RYGB [6-8]. Moreover, a number 
of studies in rodent models have demonstrated marked changes in 
intestinal volume and number of GLP-1 positive enteroendocrine 
cells following RYGB surgery, as well as altered GLP-1 and PYY 
mRNA gene expression in the gut [9,10]. Collectively, these data 
suggest that the post-surgical effect of gastric bypass on intestinal 
morphology and endocrine cell numbers play an important role for 
the weight loss and other beneficial effects seen after RYGB surgery. 
The minipig has been proven to be a valuable animal model 
for human nutrition and obesity studies due to similarities in 
gastrointestinal tract anatomy, nutrition requirements, body size and 
metabolic characteristics [11,12]. Anatomical similarities include 
the epithelial cell types and structure of the intestinal villi [13]. 
Furthermore, pigs are omnivores and their diet composition, gastric 
pH and digestive effectiveness resemble that of humans [12]. In 
response to both feeding and fasting the release of gut hormones such 
as ghrelin, leptin and PYY has been shown to mirror that of humans 
Pernille Barkholt1*, Andreas Vegge2,3, Trine Ryberg 
Clausen3, Malene Muusfeldt Birck4, Johannes 
Josef Fels3, Mikael Støckel5, Ismail Gögenur5, 
Thomas Eriksen6, Jens Juul Holst7, Axel Kornerup 
Hansen4, Thomas Thymann2, Jacob Jelsing1, Per 
Torp Sangild2 and Kirsten Raun3
1Department of Histology, Gubra, Hørsholm, Denmark 
2Department of Nutrition, Exercise and Sports, Faculty of Science, 
University of Copenhagen, Denmark 
3Diabetes research unit, Novo Nordisk A/S, Måløv, Denmark
4Department of Veterinary Disease Biology, Faculty of Health and 
Medical Sciences, University of Copenhagen, Denmark 
5Department of Surgery, Copenhagen University Hospital, Herlev, 
Denmark
6Department of Veterinary Clinical and Animal Science, Faculty of 
Health and Medical Sciences, University of Copenhagen, Denmark 
7Novo Nordisk Foundation, Centre of Basic metabolic Research, 
Department of Biomedical Sciences, Panum Institute, Copenhagen, 
Denmark
*Address for Correspondence
Pernille Barkholt, Department of Histology, Gubra, Agern Allé 1, 2970 
Hørsholm, Denmark, Tel: +45 31522650; E-mail: pb@gubra.dk  
Submission: 03 January 2015
Accepted: 19 January 2015
Published: 24 January 2015
Reviewed & Approved by: Dr. Francesco Saverio Papadia, 
Assistant Professor of Surgery, University of Genoa School of Medicine, 
Italy
Case ReportOpen Access
Journal of
Obesity and 
Bariatrics
Avens Publishing Group
Inviting Innovations
Avens Publishing Group
Inviting Innovations
Citation: Barkholt P, Vegge A, Clausen TR, Birck MM, Fels JJ, et al. Post-Surgical Effects of Roux-En-Y Gastric Bypass on Glucose Homeostasis, 
Intestinal Morphology and L-Cells in Obese Göttingen Minipigs. J Obes Bariatrics. 2015;1(1): 8.
J Obes Bariatrics  1(1): 8 (2015) Page - 02
[14,15] collectively making the pig a useful model for studying aspects 
of human nutrition [16] and gastrointestinal disorders [17,18].
The Göttingen minipig has the same anatomical and physiological 
features as the domestic pig but their smaller size and a growth 
phase that is more comparable with that of humans, give them an 
advantage as experimental models [19,20]. On a restricted diet, the 
adult Göttingen minipig weighs 35-40 kg. However, when given ad 
libitum access to food especially the females will overeat and reach a 
body weight of more than 100 kg by 18 months of age [21,22]. This 
leads to a model of obesity that is more similar to human obesity than 
rodent models with respect to body composition [22-24]. In addition, 
obese minipigs have been reported to develop mild insulin resistance 
while maintaining normal glucose tolerance which is similar to 
observations in some obese humans [20,25]. Previous studies have 
shown that RYGB in minipigs induces an increase in both fasted 
and postprandial ghrelin levels whereas plasma levels of PYY remain 
unchanged [26]. Furthermore, two recent studies have examined 
physiological effects of RYGB in lean pigs. One study shows that 
RYGB in young castrated male lean pigs leads to increased β-cell mass, 
improved glycemic control and increased number of pancreatic GLP-
1 receptor positive cells [27]. Whereas the other paper demonstrates 
elevated postprandial insulin and GLP-1 levels following RYGB 
in lean Göttingen minipigs [28]. However, until now the majority 
of RYGB studies in pigs have focused on method development or 
short-term survival, and all studies have been performed in lean pigs 
[26,29]. So far no studies have investigated the postsurgical effects 
of RYGB on the small intestine and glucose metabolism in obese 
Göttingen minipigs.
The aim of the current study is to characterize post-surgical 
changes in intestinal morphology and number of L-cells in obese 
RYGB Göttingen minipigs, and to correlate these changes to weight 
loss and plasma hormone levels, such as GLP-1.
Methods
Animals
Eleven female ovariectomized obese Göttingen minipigs 
(Ellegaard Göttingen minipig A/S, Denmark) aged 4-6 years 
underwent laparoscopic RYGB surgery. At the time of surgery, 
body weight ranged from 88-122 kg. This is more than double of 
what is considered normal body weight for Göttingen minipigs, and 
resembling morbid obesity in humans [11]. Diet-induced obesity 
was initiated by giving ad libitum access to standard minipig chow 
(Altromin 9023, Brogaarden, Denmark). Animals were single 
housed in pens with straw bedding and free access to water. Two 
days prior to surgery, the pigs had access to limited liquid diet only 
(Nutridrink Cocoa, Nutricia, Denmark) and three to four weeks 
after surgery animals were gradually returned to ad libitum chow. 
Three ovariectomized obese minipigs with a body weight of 91-111 
kg were included as non-operated controls. Animals were treated in 
accordance with the Animal Experimentation Act of Denmark, which 
is in accordance with the Council of Europe Convention ETS 123. 
All animal experiments were approved by the Danish Committee for 
Animal Research (permit number 2012-15-2934-00058).
Surgery
Approximately one month before RYGB surgery, two central 
venous catheters were surgically implanted in the external jugular 
vein during anesthesia [30].
A detailed description of the anesthesia, the RYGB surgical 
procedure and the pre- and post-surgical management of the 
minipigs has been described elsewhere [30]. Briefly, a gastric pouch 
of estimated 20-30 mL was created along the lesser curvature of the 
stomach with the remaining part of the stomach being bypassed. A 
gastro-jejunostomy was created between the jejunum 120 cm aborally 
from the duodenum and the gastric pouch. Following, another 240 
cm of the intestine a jejuno-jejunostomy was created, right next to the 
initial gastro-jejunostomy. By dividing the intestine between the two 
anastomoses a biliopancreatic limb of 120 cm, an alimentary limb of 
240 cm and a common limb of 500-600 cm were created.
Mixed meal test (MMT)
An MMT was performed before surgery as well as one month and 
three months after surgery in the five RYGB animals. Animals were 
fasted overnight with free access to water. 200 mL of Nutridrink Cocoa 
(per 100 mL: 1260 kJ, 6.0 g protein, 5.8 g fat, 18.4 g carbohydrate) 
was administered intraorally at t=0. Blood samples for plasma 
leptin and GLP-1 analyses were collected at t=-10, -5, 0, 15, 30, 45, 
60, 90, 120, 180 and 240 minutes through one of the central venous 
catheters. Blood was collected in tubes containing EDTA (8 mM, 
Sigma #E0270), DPPIV inhibitor (1 µg/ml blood, Linco DPP4-010), 
protease inhibitor cocktail (10 µl/ml blood, Sigma #P8340), Pefabloc 
SC (AEBSF) (10 µl/ml blood, Roche#11 429 868 001), and aprotinin 
(500 KIE/ml blood, Trasylol, Bayer). Plasma was separated and stored 
at -80 °C until further analysis.
Intravenous glucose tolerance test (IVGTT)
Prior to surgery and one month post-operatively an IVGTT was 
performed in the five RYGB animals. Animals were fasted overnight 
with free access to water. At t=0 a bolus 0.3 g/kg of a 50% sterile 
glucose solution was administered intravenously through one of 
the central venous catheters. Blood samples for glucose, insulin and 
C-peptide were taken through the second catheter at t=-10, -5, 1, 3, 
5, 7, 10, 15, 20, 25, 30, 40 and 55 minutes. Plasma was separated and 
stored at -80°C until further analysis. Plasma glucose was measured 
immediately after centrifugation by transferring 10 µL of plasma 
into 500 µL EBIO solution and measured on a Biosen auto analyzer 
(BIOSEN S Line, EKF Diagnostics, Cardiff, UK) according to the 
manufacturer’s instructions.
Assays
GLP-1 and leptin levels were measured in plasma from MMT and 
plasma insulin and C-peptide were measured from IVGTT. Intact 
GLP-1, insulin and c-peptide were measured using Luminescence 
Oxygen Channeling Immunoassays (LOCI) as described previously 
[31]. Two monoclonal antibodies against GLP-1 (mAbF5 [32] and 
mAb26.1 [33] recognizing different epitopes were used in the GLP-
1 assay. For insulin and C-peptide in-house monoclonal antibodies 
recognizing different epitopes of porcine insulin and porcine 
C-peptide respectively were used. All samples were measured in 
duplicate and results reported as the mean of duplicates.
Leptin was measured in EDTA-stabilized plasma using a multi-
species Leptin RIA kit (Millipore, Cat # XL-85K) according to 
the manufacturer’s protocol. Results are reported as the mean of 
duplicates.
Tissue sampling
Eight to nine months after surgery the pigs were euthanized with 
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an overdose of pentobarbital. The entire small bowel was sampled 
immediately after termination and the lengths of alimentary, 
biliopancreatic and common limbs were recorded. Tissue samples 
were obtained from each of the three limbs using systematic 
uniform random sampling (SURS) principles ensuring an unbiased 
representation of the entire region [34]. Using this principle, eight 
transverse biopsies were obtained from each limb. The biopsies 
were immersion fixed in 4% formaldehyde and stored at 4°C until 
further processing. In the control animals, the three limbs of the 
small intestine were delineated based on the averaged limb length 
in the operated animals (16% alimentary, 18% biliopancratic and 
66% common limb). The corresponding intestinal segments of these 
animals were then sampled in the same way as the RYGB operated 
animals using SURS.
Embedding and sectioning
The eight biopsies from each limb were paraffin infiltrated 
overnight and then embedded in paraffin blocks, one biopsy in 
each block. The blocks were subsequently cut in 5 µm thick sections 
using a Microm HM340E (Thermo Scientific, Walldorf, Germany) 
and collected on glass object slides (Thermo Scientific, Walldorf, 
Germany). One series consisting of one section from each biopsy 
was collected for histochemical staining and subsequent analysis 
of mucosal surface and volume. Another series consisting of two 
consecutive sections arranged on one object slide was collected for 
immunohistochemical staining and L-cell quantification.
Histochemical and immunohistochemical staining
Quantitative evaluation of intestinal volume and mucosal 
surface was conducted on haematoxylin-eosin (HE) using Mayer’s 
Haematoxylin solution (MHS32-1L, Sigma Aldrich) and Eosin B 
solution (HT110280, Sigma-Aldrich). GLP-1 immunohistochemistry 
was performed according to standard staining protocols [10,35] 
using a primary mouse anti-GLP-1 antibody (GLPa-1F5 0P009, 
1:1000) in combination with EnVision+ HRP labelled polymer anti-
mouse (K4007, DAKO, Denmark) using a diaminobenzidine (DAB) 
as chromogen (K3468, DAKO, Denmark). All slides were scanned 
and digitized using an Aperio ScanScope AT slide scanner (Aperio, 
California, USA) with a 20x objective.
Stereological quantification of regional volumes and 
mucosa surface
All stereological parameters were estimated using the new 
CAST software (Visiopharm, Hørsholm, Denmark) on digital slides. 
Volumes of the intestinal wall were estimated in each of the different 
intestinal limbs using point counting, and converted into volume 
using the principle of Cavalieri: 
∑ ××=   tA  PV pointref
Where ∑p is the total number of points hitting the structure of 
interest, Apoint is the area associated with each grid point and t is the 
distance between sections [36]. 
Estimation of the inner mucosal surface area was performed by 
counting intersections between linear probes and the luminal side of 
the intestine [34,35]. The absolute surface area was estimated by the 
relationship between intersection and point counts multiplied with 
the reference volume: 
ref
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V  
P  l
I  2
  S ×
×
×
=
∑
∑
Where ∑I is the number of intersections of the test lines with the 
epithelium of the tunica mucosa, lprobe is the length of the test line and 
∑P is the number of test points hitting the reference volume. 
Stereological quantificationtion of L-cell number
The total number of GLP-1 immunoreactive L-cells was estimated 
using the principle of the physical dissector [34] at an on-screen 
magnification of 640x. The numerical density (Nv) of L-cells was 
estimated by counting cells within a reference volume [36]:
∑
∑
××
=
−
  t a  P
Q
  N
frame
V
Subsequently, the total number of L-cells was obtained by 
multiplying the numerical density with the total mucosa volume.
Statistical evaluation
Graphical presentations, calculations and statistical analyses 
were carried out using GraphPad software (GraphPad Prism version 
5.04, California USA). Graphical presentations illustrate individual 
data as well as linear correlations (evaluated by Pearson correlation 
test). Tables present data of control (n=3), non-responders (n=3) and 
responders (n=2). Due to the low numbers of animals, no statistical 
analyses were performed between groups. Data are presented as mean 
± standard error of the mean (SEM). 
Results
Survival and body weight
Five successfully RYGB operated animals were included in this 
study and compared with three non-operated obese controls. The six 
remaining animals that underwent RYGB surgery were euthanized 
pre-maturely due to surgical or central venous catheter related 
complications and therefore excluded from further analyses (see 
[30]). Initially, all five RYGB animals lost weight with an average 
weight loss of 9.1 ± 0.9% eight weeks post-surgery. One animal 
continuously lost weight throughout the study (RYGB 1) whereas one 
animal started to slowly regain weight from 10 weeks after surgery 
(RYGB 2). RYGB 1 and RYGB 2 are referred to as responders and 
maintained a reduced body weight throughout the experimental 
period (86 ± 12% compared to their pre-surgical weight) (Figure 1). 
In contrast, three animals started to regain weight approximately two 
months post-surgery, eventually leading to a body weight exceeding 
the body weight at time of surgery (108 ± 1.3% compared to their 
pre-surgical weight) (Figure 1). These animals are referred to as non-
responders (RYGB 3, 4 and 5).
Plasma hormones
Area under curve analysis of plasma glucose, insulin and c-peptide 
in response to intravenous glucose administration, showed similar 
levels of these hormones between responders and non-responders 
compared with pre-surgery levels (Table 1). 
Fasting leptin levels were decreased for both responders and 
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non-responders one month post-surgery compared with pre-surgical 
levels and the decrease remained at three months post-surgery (Table 
2). The improvement in leptin levels was most pronounced in the 
responder animals. The leptin levels did not change in response to the 
mixed meal (data not shown). Fasting plasma levels of GLP-1 were 
unchanged after surgery, however, increased in response to the MMT 
at one and three months post-surgery in both responder and non-
responder animals compared with pre-surgical levels (Table 2). 
Gut morphology
Representative images of gut morphology for the alimentary limb 
of control animals, responders and non-responders are shown in 
Figure 2. 
The length of the alimentary limb was identical between control 
and non-responder animals. Whereas, in responder animals this limb 
was 1.4 times longer than in both controls and non-responders (Table 
3 and Figure 3A). A significant linear correlation between length of 
alimentary limb and body weight change was observed (Figure 3B).
The volume of the entire small intestinal was increased in all RYGB 
animals compared with the control animals (Figure 3C). Responder 
animals had a slightly larger volume than the non-responders (Table 
4), however, no significant correlation between volume of the small 
intestine and body weight change was detected (Figure 3D). The 
hypertrophy was most pronounced in the alimentary limb and 
assessment of individual animals showed that the two responder 
animals had the highest degree of gut hypertrophy in alimentary limb 
volume (Figure 3E). As shown in Table 4 responders had a 2.7 fold 
larger alimentary limb volume than controls and a 1.8 fold increase 
compared with non-responders. Correlation analyses of individual 
body weight changes and individual alimentary limb volumes for 
the five RYGB animals demonstrated a significant linear relationship 
between weight loss and intestinal volume (Figure 3F). 
Number of L-cells and GLP-1 levels
L-cells were identified by GLP-1 immunohistochemistry and 
representative images of control and RYGB animals are shown 
in Figure 4. The assessment of individual animals showed that the 
two responders had the highest total number of L-cells in the small 
intestine though no significant linear correlation was observed 
between total number of L-cells and weight change (Figures 5A and 
5B). The hyperplasia was most pronounced in the alimentary limb, 
in fact in the alimentary limb the responder animals had a 3.0 fold 
increase in L-cell numbers compared with control animals and a 2.5 
fold increase compared with non-responders (Table 5). Correlation 
analysis demonstrated a significant linear relationship between 
increased weight loss and number of L-cells in the alimentary limb of 
the five RYGB animals (Figure 5D). The increase in L-cell numbers in 
RYGB animals corresponded well with the increase in postprandial 
GLP-1 levels three months post-surgery, relative to their pre-surgery 
levels (Figures 5E and 5F). 
Discussion
The present study aimed to investigate the effect of RYGB surgery 
on weight loss, hormone secretion, intestinal morphology and 
L-cell numbers in obese Göttingen minipigs. Using mathematically 
unbiased stereological methods, we report that RYGB surgery leads 
to a marked hypertrophy of the small intestine, in particular in the 
alimentary limb, an increased total number of L-cells, increased 
postprandial GLP-1 levels and decreased leptin levels. These 
findings are in line with previous reports from preclinical studies 
in rats [9,10,37] and clinical observations from humans [7,8,37-39]. 
Furthermore, we report for the first time, data resulting from RYGB 
surgery in the obese Göttingen minipig, demonstrating a linear 
relationship between body weight loss, gut hypertrophy and L-cell 
numbers in responder versus non-responder animals. Collectively, 
the data suggest that the changes in the alimentary limb may be the 
key determinant to the success of RYGB surgery. 
Figure 1: Body weight change. Body weight change in individual animals 
relative to body weight one week before surgery.
Figure 2: Gut morphology. Representative micrographs of gut morphology 
in the alimentary limb of control non-operated minipigs, non-responder and 
responder RYGB operated minipigs. Sections were stained with haematoxylin 
and eosin.
Baseline 
(pre-surgery)
Non-responder 
(RYGB 3, 4 and 5) 
Responder 
(RYGB 1 and 2) 
C-peptide
AUC
31.5 ± 3.1 pg/mL 
x min
37.3 ± 2.4 pg/mL 
x min
39.9 ± 1.1 pg/mL 
x min
Plasma 
glucose 
AUC
622 ± 41 mM x min 605 ± 111 mM x min 661 ± 86 mM x min 
Insulin 
AUC
36 358 ± 4 487 pM 
x min 
34 585 ± 5 960 pM 
x min 
40 514 ± 10 002 pM 
x min 
Table 1: Levels of plasma hormones in response to intravenous glucose bolus.
C-peptide, glucose and insulin plasma levels pre-surgery (n=5) and one month 
post-surgery in non-responder (n=3) and responder (n=2) animals. All values are 
presented as mean ± SEM.
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1 month post-surgery 3 months post-surgery
Baseline 
(pre-surgery)
Non-responder 
(RYGB 3, 4 and 5)
Responder 
(RYGB 1 and 2)
Non-responder 
(RYGB 3, 4 and 5)
Responder 
(RYGB 1 and 2)
Leptin
Fasting 15.95 ± 1.52 mM 9.53 ± 1.42 mM 8.12 ± 1.37 mM 10.19 ± 0.67 mM 7.74 ± 0.58 mM
GLP-1
Fasting 3.11 ± 0.19 pM 2.99 ± 0.94 pM 3.08 ± 0.36 pM 3.01 ± 0.86 pM 2.78 ± 0.36 pM
GLP-1
AUC 315 ± 37 pM 
x min 1491 ± 718 pM x min 1071 ± 116 pM x min 2350 ± 1220 pM x min 2412 ± 845 pM x min
Table 2: Levels of plasma hormones in response to oral mixed meal.
Leptin and GLP-1 hormone levels pre-surgery (n=5) as well as one and three months post-surgery in non-responder (n=3) and responder (n=2) animals. All values 
are presented as mean ± SEM.
Figure 3: Gut hypertrophy. Length of alimentary limb (a) and correlation with body weight change (b) Volume of intestinal wall in entire small intestine (c) and 
correlation with body weight change (d) Volume of intestinal wall in alimentary limb (e) and correlation with body weight change (f) Pearson’s correlation test for 
all correlation analyses.
  
Control 
(control A, B and 
C) 
Non-responder 
(RYGB 3, 4 and 5) 
Responder 
(RYGB 1 and 2) 
Small intestine 921 ± 56 cm 1049 ± 74 cm 1001 ± 151 cm 
Biliopancreatic 
limb 149 ± 9 cm 152 ± 30 cm 178 ± 13 cm 
Alimentary limb 167 ± 10 cm 161 ± 10 cm 226 ± 14 cm 
Common limb 605 ± 37 cm 736 ± 42 cm 598 ± 153 cm 
Table 3: Length of limbs in the small intestine.
Length of intestinal limbs and the complete small intestine in control (n=3), non-
responder (n=3) and responder (n=2) animals at termination. All values are 
presented as mean ± SEM.
In this study we observed an alimentary limb that was 1.4 times 
longer in responder animals than in both control and non-responder 
animals, indicating that the length of this limb may be important for 
the success of RYGB surgery. Previous reports from clinical studies 
suggest that a longer alimentary limb is associated with an improved 
success of surgery (sustained weight loss) in super obese patients 
(BMI>50) [40-42] thereby supporting our findings. The difference in 
limb length in our study may of course be related to surgical variation, 
as it is very difficult to measure the lengths of the individual intestinal 
segments during the laparoscopic procedure. However, with a 3.0 fold 
increase in volume and a 2.7 fold increase in number of L-cells in the 
alimentary limb of responders compared with controls it is evident 
that these increases exceed the difference in length and demonstrates 
that post-surgical intestinotrophic effects are definitely taking place. 
Resting energy expenditure has been shown to be enhanced in animal 
models of gastric bypass and intestinal hypertrophy is expected to be 
a significant component of this [37,43]. The increased hypertrophy 
associated with a longer alimentary limb may therefore at least 
partially explain why these animals have an improved weight loss in 
our study.
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A similar effect of RYGB on intestinal hypertrophy has still not 
been demonstrated in humans and the underlying intestinotrophic 
mechanism remains elusive. It has been speculated that enhanced 
mechanical or nutrient stimulation in distal segments of the intestine 
may be involved in the hypertrophy [9,44,45]. This hypothesis is 
emphasized by the lack of volume change in the biliopancreatic 
limb where food is not present and previous findings in rats [10,44]. 
When mechanical and/or nutrient stimulation is missing (e.g. 
during starvation) the gut undergoes atrophy [46]. An alternative 
component of gut hypertrophy may be GLP-2, a key mediator of 
nutrient-stimulated epithelial proliferation, [47] which is co-secreted 
with GLP-1 from the L-cell in a 1:1 stoichiometric ratio [48]. GLP-2 
has been demonstrated to be a very potent stimulator of intestinal 
proliferation in both adult rats [47] and newborn pigs [17,49] and the 
stimulation of L-cell number and subsequent increase in total GLP-
2 secretion could provide a positive feedback mechanism. In this 
respect, it should be noted that elevated GLP-2 plasma measurements 
previously have been documented in RYGB animal models and in 
man [7,37]. 
Despite the high number of L-cells in the common limb, the 
largest alteration between responder and non-responder animals was 
found to be restricted to the alimentary limb. An approximately 2.5 
fold increase in L-cell number in the responder animals compared 
with non-responders substantiates that this region may be central 
to the gut endocrine response to RYGB. Interestingly, we observed 
a strong correlation between the increased number of L-cells and the 
increased postprandial levels of circulating GLP-1. Elevated post-
surgical levels of GLP-1 have also been reported in both pre-clinical 
and clinical studies of RYGB surgery [6-8] and are considered to play 
a prominent role in the rapid normalization of glycemia following 
RYGB [50]. In the present study, pigs were neither hyperglycemic 
nor glucose intolerant [25], making it impossible to assess potential 
effects on glycemic control. Our findings regarding both elevated 
postprandial GLP-1 levels and unchanged glycemia is in agreement 
with findings in lean RYGB operated Göttingen minipigs [28]. In 
contrast, the recent paper by Lindqvist and co-workers indicated 
improvements in glycemic control and pancreas function following 
RYGB surgery in castrated young male pigs compared with sham 
operated animals [27]. However, the sham operated controls had 
fasting blood glucose over 10 mM which is surprising, as to the best 
of our knowledge no other studies have been able to demonstrate 
diabetic glucose levels in pigs.
Previous studies indicate that the Göttingen minipig may be 
superior relative to rodents in studies of severe obesity [22,25]. 
However, so far most gastric bypass studies in pigs have focused 
on surgical development or short term survival and include lean 
animals only[26,29]. Specific anatomic features in minipigs, such 
as the very thick stomach wall, dense peritoneum and thin small 
bowel necessitate modifications to the standard RYGB procedure 
in man [26]. In the five animals that completed the protocol we 
observed a marked inter-individual weight response to the surgery 
with two animals losing weight and three animals regaining weight. 
Weight regain after RYGB has also been reported in humans with 
complete weight regain in up to 10% of super obese patients [51,52]. 
In our study, a weight loss success rate of two out of five successfully 
operated minipigs was however unexpected. Thus, even though we 
demonstrate that RYGB surgery of obese Göttingen minipigs is 
feasible, further surgical optimizations are needed to validate this 
species as an important translational RYGB model.
A main limitation in our study was the lack of sham-operated 
control animals. However, we consider it unlikely that the observed 
adaptations occurred as a response to anesthesia and the extensive 
manipulation of the visceral organs only, which is supported by 
data from rats demonstrating no effect of sham surgery on intestinal 
volume or L-cell numbers when compared to naive controls [9,10]. 
Control 
(control A, B 
and C) 
Non-responder 
(RYGB 3, 4 
and 5) 
Responder 
(RYGB 1 and 2) 
Volume
Small intestine 64.11 ± 4.02 cm3 103.20 ± 3.39 cm3 119.86 ± 11.15 cm
3
Biliopancreatic 
limb 11.80 ± 0.29 cm
3 9.16 ± 0.52 cm3 18.00 ± 2.98 cm3 
Alimentary limb 12.40 ± 0.76 cm3 18.85 ± 1.28 cm3 33.42 ± 4.72 cm3
Common limb 39.83 ± 3.87 cm3 75.23 ± 4.13 cm3  (*) 70.45 ± 18.85 cm
3 
Surface
Small intestine 3620 ± 493 cm2 4918 ± 648 cm2 5994 ± 54 cm2
Biliopancreatic 
limb 646 ± 101 cm
2 355 ± 23 cm2 737 ± 335 cm2
Alimentary limb 647 ± 49 cm2 931 ± 156 cm2 1763 ± 404 cm2 (*)
Common limb 2327 ± 347 cm2 3633 ± 589 cm2 3493 ± 685 cm2
Table 4: Volume and mucosal surface of small intestine.
Volume of the intestinal wall as well as inner mucosal surface in control (n=3), 
non-responder (n=3) and responder (n=2) animals. All values are presented as 
mean ± SEM.
  Control (control A, B and C) 
Non-responder 
(RYGB 3, 4 
and 5) 
Responder 
(RYGB 1 and 2) 
Small intestine 263 ± 27 mill 335 ± 43 mill 482 ± 14 mill
Biliopancreatic 
limb 13.4 ± 0.89 mill
 11.2 ± 0.94 mill 25.0 ± 16 mill 
Alimentary limb 35.8 ± 3.5 mill 42.5 ± 2.8 mill 110 ± 36 mill
Common limb 213 ± 28 mill 281 ± 45 mill 347 ± 61.1 mill 
Table 5: Number of L-cells in small intestine.
Absolute number of L-cells in the small intestine and the intestinal limbs in 
control (n=3), non-responder (n=3) and responder (n=2) animals. All values are 
presented as mean ± SEM.
Figure 4: GLP-1 immunohistochemical staining. Representative 
micrographs of GLP-1 immuno staining in the alimentary limb of control non-
operated minipigs, non-responder and responder RYGB operated minipigs. 
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In conclusion, we report that RYGB in obese Göttingen minipigs 
is associated with hypertrophy of the gut, an increase in absolute 
L-cell numbers, elevated postprandial GLP-1 levels and decreased 
leptin levels. Our data suggest that the alimentary limb may be a 
potential key mediator of the post-surgical effects of RYGB with a 
significant correlation between morphological changes in this limb 
and body weight loss. 
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